Literature DB >> 29017285

Reply to Corona and Cattaneo.

Roger L Nation1, Samira M Garonzik2, Visanu Thamlikitkul3, Evangelos J Giamarellos-Bourboulis4, Alan Forrest2, David L Paterson5, Jian Li1, Fernanda P Silveira6.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29017285      PMCID： PMC5849108          DOI： 10.1093/cid/cix390

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Dosing Colistin Properly: Let's Save "Our Last Resort Old Drug!"

Authors:  Alberto Corona; Dario Cattaneo
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

2.  Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.

Authors:  Ilias Karaiskos; Lena E Friberg; Lambrini Galani; Konstantinos Ioannidis; Emmanouela Katsouda; Zoe Athanassa; Harris Paskalis; Helen Giamarellou
Journal:  Int J Antimicrob Agents       Date:  2016-07-18       Impact factor: 5.283

3.  Dosing guidance for intravenous colistin in critically-ill patients.

Authors:  Roger L Nation; Samira M Garonzik; Visanu Thamlikitkul; Evangelos J Giamarellos-Bourboulis; Alan Forrest; David L Paterson; Jian Li; Fernanda P Silveira
Journal:  Clin Infect Dis       Date:  2016-12-23       Impact factor: 9.079

4.  Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.

Authors:  Andrew A Udy; Julie M Varghese; Mahdi Altukroni; Scott Briscoe; Brett C McWhinney; Jacobus P Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

5.  Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors:  S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

6.  Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.

Authors:  Ilias Karaiskos; Lena E Friberg; Konstantinos Pontikis; Konstantinos Ioannidis; Vasiliki Tsagkari; Lamprini Galani; Eirini Kostakou; Fotini Baziaka; Charalambos Paskalis; Antonia Koutsoukou; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

7.  Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?

Authors:  Roger L Nation; Samira M Garonzik; Jian Li; Visanu Thamlikitkul; Evangelos J Giamarellos-Bourboulis; David L Paterson; John D Turnidge; Alan Forrest; Fernanda P Silveira
Journal:  Clin Infect Dis       Date:  2015-11-25       Impact factor: 9.079
  7 in total
  1 in total

1.  Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment.

Authors:  Daniele Roberto Giacobbe; Alessandra di Masi; Loris Leboffe; Valerio Del Bono; Marianna Rossi; Dario Cappiello; Erika Coppo; Anna Marchese; Annarita Casulli; Alessio Signori; Andrea Novelli; Katja Perrone; Luigi Principe; Alessandra Bandera; Luca Enrico Vender; Andrea Misin; Pierpaolo Occhilupo; Marcello Melone; Paolo Ascenzi; Andrea Gori; Roberto Luzzati; Claudio Viscoli; Stefano Di Bella
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.